Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jan 28 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-28-2021-8

Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 28, 2021, titled "Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases